Scleral Lens Market Industry Growth Prospects and Emerging Trends 2034

Scleral lenses are large-diameter gas-permeable contact lenses designed to vault over the cornea and rest on the sclera. These lenses create a fluid reservoir between the lens and the corneal surface, providing superior comfort and visual acuity for patients with complex eye conditions. Scleral lenses are widely used for managing keratoconus, irregular corneas, post-surgical complications, severe dry eye syndrome, and other ocular surface diseases. The growing awareness among eye care professionals and patients regarding the therapeutic benefits of scleral lenses has led to increased adoption across hospitals and eye clinics. Their ability to improve visual outcomes and enhance patient comfort has positioned scleral lenses as a preferred alternative to traditional soft lenses and spectacles.

The global Scleral Lens Market in 2026 is witnessing significant growth, driven by the rising prevalence of ocular disorders, increasing adoption of advanced vision correction solutions, and continuous technological innovations in ophthalmic care. according to fortune business insights, In 2025, the global scleral lens market was valued at USD 356.62 million and is projected to grow from USD 390.91 million in 2026 to USD 1,016.99 million by 2034, registering a strong CAGR of 12.70% during the forecast period. This rapid expansion highlights the increasing importance of scleral lenses in modern eye care.

Market Drivers and Growth Factors

The increasing incidence of corneal disorders and dry eye conditions is one of the primary drivers of the scleral lens market. As the global population ages, the number of individuals experiencing vision impairment continues to rise, creating sustained demand for advanced contact lens solutions.

Technological advancements in lens design and manufacturing have further contributed to market growth. Innovations such as improved oxygen permeability, customizable lens parameters, and simplified fitting techniques have enhanced patient comfort and reduced fitting complexity for practitioners. In addition, favorable reimbursement policies in certain regions have encouraged patients to opt for scleral lenses, supporting market expansion.

Market Restraints

Despite strong growth prospects, the scleral lens market faces several challenges. High costs associated with scleral lenses, including fitting, refitting, and maintenance expenses, can limit adoption, particularly in price-sensitive markets. The requirement for skilled professionals to ensure proper fitting also acts as a barrier, as inadequate fitting may lead to complications such as discomfort, fogging, or reduced oxygen transmission.

Furthermore, the availability of alternative vision correction options, including soft contact lenses and refractive surgeries, may restrain market growth in certain segments.

Market Report Coverage

The scleral lens market report provides an in-depth analysis of market size, growth trends, key drivers, restraints, competitive landscape, segmentation, and regional performance. The report examines the impact of technological advancements and strategic initiatives undertaken by leading companies to strengthen their market presence.

Market Segmentation

By Type

Based on type, the market is segmented into mini-scleral lenses and large scleral lenses. Mini-scleral lenses are expected to dominate the market, accounting for a major share due to their growing use in treating keratoconus and dry eye syndrome. Their smaller diameter, ease of fitting, and enhanced comfort have contributed to their widespread adoption.

Large scleral lenses also hold a notable share, particularly in cases requiring greater corneal vaulting and stability. These lenses are increasingly preferred for patients with severe corneal irregularities.

By End User

By end user, the market is categorized into hospitals, eye clinics, and others. Eye clinics are projected to lead the market, supported by the increasing number of specialized eye care centers and independent optometrists offering scleral lens fitting services. Hospitals represent the second-largest segment due to rising investments in advanced ophthalmic infrastructure.

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/scleral-lens-market-106557 

Market Competitive Landscape

The global scleral lens market is moderately consolidated, with leading players focusing on product innovation, strategic collaborations, and geographic expansion. Companies are investing in research and development to introduce advanced lens designs that improve patient outcomes and streamline fitting processes.

Top Companies in the Scleral Lens Market:

• Bausch + Lomb (Canada)

• EssilorLuxottica (France)

• ABB Optical Group (U.S.)

• The Cooper Companies Inc. (U.S.)

• Art Optical Contact Lens, Inc. (U.S.)

• Visionary Optics (Euclid Vision Group) (U.S.)

• BostonSight (U.S.)

• TruForm Optics Inc. (U.S.)

• SynergEyes (U.S.)

• AccuLens (U.S.)

Market Regional Insights

North America dominated the global scleral lens market in 2025, accounting for a market share of 40.22%. The region’s leadership is attributed to advanced healthcare infrastructure, high awareness of scleral lenses, and the strong presence of key market players.

Europe holds the second-largest share, supported by increasing adoption of scleral lenses for dry eye management and post-surgical vision correction. The Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by a growing patient population, improving access to eye care services, and rising awareness regarding advanced contact lenses.

Future Market Scope

The future of the scleral lens market looks promising, with increasing investments in product innovation and expanding therapeutic applications. In May 2024, Bausch + Lomb announced the launch of Zenlens ECHO scleral lenses in the U.S., strengthening the company’s footprint in the global market.

Continued advancements in lens materials, digital fitting technologies, and customization options are expected to further enhance market growth. As awareness increases and access to specialized eye care improves, the adoption of scleral lenses is anticipated to rise steadily across both developed and emerging economies.

Contact us:Fortune Business Insights™ Pvt.Phone: USA: +1 833 909 2966 (Toll-Free),United Kingdom: +44 808 502 0280 (Toll-Free),APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.com